Value £3,700,000

PlaqueTec

VC Funding

Series A

Healthcare & Biotech Published 27 April 2026

Summary

PlaqueTec has raised £3.7m in an oversubscribed financing round funded by its existing investor base to develop its cardiovascular disease database.

Summary of transaction details:

Value: £3.7m
Sector: Healthcare & Biotech
Advisor: Not disclosed
Key Entities: PlaqueTec, existing investor base
Location: Cambridge, UK

Note: The funding will support the continued build-out of PlaqueTec's proprietary cardiovascular data lake, BioCarta, which aims to provide a novel site-of-disease strategy to inform how inflammatory risk in CVD is targeted.

Lead Investor / Acquirer

Undisclosed Group

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series A prioritised

VC Funding

Antiverse

£7,000,000

Mar 2025

VC Funding

Apposite Healthcare Growth I

£100,000,000

Apr 2026

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

SatVu

£30,000,000

Mar 2026

View Company Details

Financials, officers, full deal history

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.